EG 427 to hold poster presentation on lead asset EG110A at ESGCT
October 10, 2023EG 427 announces today that it will hold a poster presentation outlining preclinical data on its lead asset EG110A at the European Society of Gene and Cell Therapy (ESGCT) 30th Annual Congress, taking place October 24-27 in Brussels, Belgium.
Julien Ratelade, Preclinical Project Manager, will present a poster on Wednesday, October 25 from 5:00-6:15pm CET and Thursday, October 26 from 8:30pm to 9:30pm CET.
Please read Press release in English and in French